Meribank Biotech Co., Ltd (TPEX:4724)
Taiwan · Delayed Price · Currency is TWD 13.05
+0.10 (0.77%)
May 8, 2026, 1:50 PM CST
Meribank Biotech Market Cap
Meribank Biotech has a market cap or net worth of 1.25 billion as of May 8, 2026. Its market cap has decreased by -9.32% in one year.
Market Cap
1.25B
Enterprise Value
2.16B
Revenue
471.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.05
Market Cap Chart
Since June 16, 2023, Meribank Biotech's market cap has decreased from 1.95B to 1.25B, a decrease of -35.64%. That is a compound annual growth rate of -14.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 1.25B | -12.93% |
| Dec 31, 2025 | 1.44B | -41.61% |
| Dec 31, 2024 | 2.46B | 2.99% |
| Dec 29, 2023 | 2.39B | 22.90% |
| Jun 16, 2023 | 1.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GenMont Biotech Incorporation | 1.50B |
| NeoCore Technology | 1.40B |
| Enimmune | 1.37B |
| Abnova (Taiwan) | 1.33B |
| Bio Preventive Medicine | 1.31B |
| BiOptic | 1.14B |
| Holy Stone Healthcare | 1.10B |
| Level Biotechnology | 1.09B |